[Antineuritic (vitamin B 1, vitamin B 12), anti-inflammatory (mefenamic acid) and central sedative (anti-epileptic) therapy in the treatment of major and minor facial algias. (Physiopathological considerations)].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D005156:Facial Neuralgia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008528:Mefenamic Acid / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D014805:Vitamin B 12; D013831:Thiamine
Terapia antineuritica (B1, B12), antiinfiammatoria (acido mefenamico) e sedative centrale (antiepilettica) nel trattamento delle algie faciali maggiori e minori. (Considerazioni fisiopatologiche)